Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2026)
Nano-X Imaging's (NNOX) quarterly Income from Continuing Operations came in at 14113000.0 in Q1 2026, down 5.23% YoY from 14892551.97 in Q1 2025, and up 61.61% on a QoQ basis from 36761000.0 in Q4 2025.
Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has 8 years of Income from Continuing Operations data on file, last reported at 14113000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 5.23% year-over-year to 14113000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79304000.0 (down 43.63% YoY) and the FY2025 annual result came in at 27274000.0, down 86.71% from the prior year.
- Income from Continuing Operations rose to 14113000.0 in Q1 2026, from 36761000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 10406000.0 in Q4 2023 to a low of 54901000.0 in Q4 2022.
- A 5-year average of 19352941.18 and a median of 14249000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations surged 81.05% — and 2025, when it slumped 157.99%.
- Tracing NNOX's Income from Continuing Operations over 5 years: stood at 54901000.0 in 2022, then surged by 81.05% to 10406000.0 in 2023, then slumped by 36.93% to 14249000.0 in 2024, then tumbled by 157.99% to 36761000.0 in 2025, then surged by 61.61% to 14113000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 14113000.0 (Q1 2026), 36761000.0 (Q4 2025), and 13872000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nano-X Imaging | 61,578.01 | -44.16 Mn | -2.59 Mn | -14.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.11 Mn |
| Dec 31, 2025 | -36.76 Mn |
| Sep 30, 2025 | -13.87 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -13.41 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -21.56 Mn |
| Jun 30, 2023 | -17.54 Mn |
| Mar 31, 2023 | -11.95 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -19.92 Mn |
| Jun 30, 2022 | -23.81 Mn |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -22.08 Mn |
| Sep 30, 2021 | -13.47 Mn |
| Jun 30, 2021 | -13.58 Mn |